<p>While we are happy to have you contact us by electronic mail, telephone, surface mail or facsimile transmission, merely communicating with Ropes &amp; Gray LLP or a Ropes &amp; Gray lawyer or employee will not create a lawyer-client relationship. Such a relationship will not arise unless and until the firm agrees with you in writing to handle a particular matter. Importantly, unless and until this has occurred, you should not convey to us any information you regard as personal or confidential, because any such information will not be treated by us as confidential or subject to any confidentiality requirements.*</p>
<p>Our Web site (<a href="http://www.ropesgray.com">www.ropesgray.com</a>) offers several opportunities for visitors to register for informational update and alert mailings, events, and for assistance in using our online resources. These registration and sign-up forms are often linked to the Ropes &amp; Gray LLP mailing list and require users to give contact information (such as name and email address). We use this contact information to send users information about our firm and their selected areas of interest when requested or necessary. Users may opt-out of receiving future mailings at any time. Ropes &amp; Gray LLP is the sole owner of information collected on this site. For more information regarding our collection and use of such information, see our Privacy Policy.</p>

This alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This alert is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. The contents are intended for general informational purposes only, and you are urged to consult your attorney concerning any particular situation and any specific legal question you may have. © 2025 Ropes & Gray LLP

Insights

Featured Insights

All Insights

Dealmaker's Digest: A Top 10 Bulletin - March 2025

SEC Issues No-Action Letter Clarifying Rule 506(c) Accredited Investor Verification

The Illumina Ban and What It Means for Life Science Companies

U.S. Private Equity Market Recap - March 2025

Culture & Compliance Chronicles: Organizational Growth Through Fostering Speaking Out and Listening Up with Megan Reitz

Talkin’ Trade: Section 337 Domestic Industry Shake-Up—Exploring the Lashify Decision

All Viewpoints

The Omnibus is Beginning to Look More Like a Minivan – The PROTECT USA Act Seeks to Scale Back the Corporate Sustainability Due Diligence Directive for U.S. Companies

Promoting Medical Device Regulatory Harmonization: Key Takeaways from the 27th IMDRF Conference in Japan

Assessing and Prioritizing Risks under the German Due Diligence in Supply Chains Act – New Guidance Issued

Addressing Supply Chain Vulnerabilities and Supply Shortages of Critical Essential Medicines: The Latest EU Legislative Proposal for a Critical Medicines Act

In Case You Missed It: February 2025 Ropes & Gray ESG, CSR and Business and Human Rights Compliance Thought Leadership

Fund Finance Symposium 2025: Industry Growth and Evolution

More Resources

Stay Up To Date with Ropes & Gray